Michael F Crutchlow

Publication Activity (10 Years)

Years Active: 2017-2019
Publications (10 Years): 5

Top Topics

Skeletal Muscle

Top Venues

Diabetes, obesity & metabolism

Endocrinology, diabetes & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Kristy Iglay, Baanie Sawhney, Alex Z Fu, Gail Fernandes, Michael F Crutchlow, Swapnil Rajpathak, Kamlesh Khunti F MedSci
Dose distribution and up-titration patterns of metformin monotherapy in patients with type 2 diabetes. Endocrinology, diabetes & metabolism 3 (1) (2019)
Juan Pablo Frias, Zachary Zimmer, Raymond L H Lam, Guillermo Amorin, Catherine Ntabadde, Carol Iredale, Edward A O'Neill, Samuel S Engel, Keith D Kaufman, Hideo Makimura, Michael F Crutchlow
Double-blind, randomized clinical trial assessing the efficacy and safety of early initiation of sitagliptin during metformin uptitration in the treatment of patients with type 2 diabetes: The CompoSIT-M study. Diabetes, obesity & metabolism 21 (5) (2019)
Philip D Home, Raymond L H Lam, Wendy L Carofano, Gregory T Golm, Roy Eldor, Michael F Crutchlow, Michael C Marcos, Julio Rosenstock, Priscilla A Hollander, Baptist Gallwitz
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open-label clinical trial. Diabetes, obesity & metabolism 20 (9) (2018)
Priscilla A Hollander, Wendy L Carofano, Raymond L H Lam, Gregory T Golm, Roy Eldor, Michael F Crutchlow, Michael C Marcos, Marc S Rendell, Philip D Home, Baptist Gallwitz, Julio Rosenstock
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open-label clinical trial. Diabetes, obesity & metabolism 20 (9) (2018)
Michael F Crutchlow, John S Palcza, Kate M Mostoller, Chantal D Mahon, April M Barbour, Michael C Marcos, Yang Xu, Elaine Watkins, Linda Morrow, Marcus Hompesch
Single-dose euglycaemic clamp studies demonstrating pharmacokinetic and pharmacodynamic similarity between MK-1293 insulin glargine and originator insulin glargine (Lantus) in subjects with type 1 diabetes and healthy subjects. Diabetes, obesity & metabolism 20 (2) (2017)